What Clients are Saying
Endorsements from parents just like you
"As a family with a history of heart disease, type 1 diabetes, and Parkinson's disease, we have to face the possibility that we may someday need treatment involving stem cells. If that day ever comes, I will want to know that we have done everything possible to prepare for a successful procedure. We've chosen Placenta-Cord banking with LifebankUSA because we understand that having more cells could make a lifesaving difference when the moment arrives."
- Christine S.,
LifebankUSA client
New Jersey
"In a recent LifebankUSA newsletter, I read about a boy with leukemia who had been saved thanks to LifebankUSA. This, along with a member of my family having died of leukemia, brought home just how important it is to bank stem cells and made me feel thankful that I had the opportunity to store my children's stem cells."
- Victoria F.,
LifebankUSA client
New Jersey
"Thanks to LifebankUSA, we became knowledgeable and confident that we were doing the right thing [for] our daughter's healthy future. It is a relief knowing our daughter's stem cells are in the hands of such a competent group of professionals."
- Peg B.,
LifebankUSA client
Texas
"I felt at ease that my doctor and his staff were very familiar with LifebankUSA's collection kit. I also appreciated LifebankUSA's flexible payment plans."
- Lauren M.,
LifebankUSA client
New Jersey
The chance that a child will use his/her own stored stem cells during his/her lifetime for currently treated conditions is estimated at 1 in 400.† These odds may increase if there is a family history of certain blood disorders or cancers. The potential risks and benefits of stem cell transplantation vary and depend on many factors, such as the amount and quality of the stem cells collected, the HLA compatibility between recipient and donor, and the client's overall health. Talk with your health care provider. For more information, call us at 1-877-LIFEBANKUSA (1-877-543-3226).
*These uses are not consistent with current labeling, are investigational and may never become standard therapy.
† Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14(3):316-322.


